Mid-Florida Cancer Centers

Orange City, Florida 32763

1 studies enrolling now · 5 studies all time

What they study most

BRCA-Associated Breast Carcinoma, BRCA-Mutated Ovarian Carcinoma, BRCA1 Mutation, Breast Cancer, Colorectal Cancer, HRD Positive Advanced Ovarian Cancer, Indolent Non-Hodgkin Lymphoma, Non-small Cell Lung Cancer, Ovarian Cancer, Pancreas Cancer, Prostate Cancer

Studies at this site

• Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer — Recruiting now
• CORRECT Study of Minimal Residual Disease Detection in Colorectal Cancer — Running, not enrolling
• A Phase 2 Study Comparing 2 Intermittent Dosing Schedules of Duvelisib in Participants With Indolent Non-Hodgkin Lymphoma — Completed
• Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid Tumors — Stopped early
• Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer — Completed